|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Intraamniotic endotoxin causes chorioamnionitis, which is followed by improved fetal lung function after 4 d in fetal sheep. We evaluated 0.1 mg, 1 mg, 4 mg, and 10 mg endotoxin for inflammation and lung maturation effects after 7 d. Four and 10 mg endotoxin caused similar lung maturation and inflammation in the lung and chorioamnion. The number of neutrophils in cord blood and the inflammatory cells in alveolar lavage and fetal lung tissue increased in a dose-dependent manner. Lower endotoxin doses induced indicators of chorioamnionitis, lung and systemic inflammation without inducing lung maturation. Therefore, some degree of inflammation can occur without subsequent lung maturation. The inflammatory changes caused by 4 mg endotoxin were assessed after 5 h, 24 h, 72 h, and 7 d to discern local versus systemic inflammation after intraamniotic endotoxin. At 5 h active inflammatory cells were in the airways producing hydrogen peroxide, and interleukin-6 and -8 were increased in the cord blood indicating both lung and systemic responses. Cells recruited into the amniotic fluid produced proinflammatory cytokine mRNA for 7 d with no cytokine mRNA in chorioamnion, lung, or spleen after 72 h. The cells in the amniotic fluid may be a source of prolonged fetal exposure to proinflammatory cytokines.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: respiratory distress syndrome; bronchopulmonary dysplasia; neutrophil recruitment; surfactant; cytokines
Prenatal exposure to inflammation/infection has been associated with numerous adverse outcomes that include preterm labor and delivery, increased risks of bronchopulmonary dysplasia (BPD), cerebral palsy, and neonatal sepsis (1). However, histological chorioamnionitis and fetal colonization with organisms such as Ureaplasma urealyticum also have been associated with a decreased incidence of respiratory distress syndrome (RDS) (4, 5), and in one epidemiological study chorioamnionitis predicted increased survival of infants born at gestations < 26 wk (6). There is very little information about how the fetus responds to intraamniotic infection/inflammation.
We have used intraamniotic injections of endotoxin to characterize the chorioamniotic and fetal lung responses to an inflammatory stimulus (7). Using a dose of 20 mg endotoxin,
we found that inflammatory cells were recruited to the chorioamnion and the chorioamnion produced interleukin (IL)-1
,
IL-6, and IL-8 mRNA within 5 h (10). The expression of the
mRNAs for the proinflammatory cytokines returned to control values within 2 d but inflammatory cells were increased in
the chorioamnion for 25 d after the endotoxin exposure (10). The
lung tissue expressed the same cytokine mRNAs within 5 h of
the intraamniotic endotoxin injection but expression was higher
at later time points and inflammatory cells also persisted in the
lungs (10). The mRNAs for the surfactant proteins increased within 24 h of endotoxin exposure and remained increased for
15 d, although lung mechanics did not improve until 4 to 7 d
after the endotoxin exposure (9). We found a minimal systemic
response to the intraamniotic endotoxin. The cord blood granulocytes initially decreased and then increased moderately
(10), fetal cortisol levels did not increase (11), and there was
no increased cytokine expression in liver, gut, or placental tissue (10). In this study we asked whether systemic or local inflammatory changes are required for subsequent lung maturation by evaluating various endotoxin doses ranging from
0.1 mg to 10 mg, and by evaluating both the systemic and local
inflammatory changes at different times after intraamniotic
endotoxin injection.
| |
METHODS |
|---|
|
|
|---|
Animals, Endotoxin, Delivery, and Postnatal Assessment
The animal component of the studies was performed in Western Australia, as approved by the animal care and use committees from Children's Hospital Medical Center, Cincinnati, OH, the Ethics Committee of the Western Australian Department of Agriculture, and the University of Western Australia. Date bred Merino ewes with a singleton fetus were randomized for the two protocols (Table 1). To evaluate the response to endotoxin dose, animals were randomized to saline, 0.1, 1, 4, or 10 mg Escherichia coli 055:B5 endotoxin (Sigma, St. Louis, MO), given 7 d before preterm delivery at 125 d gestation. To evaluate the inflammatory responses by time interval from endotoxin exposure other animals were randomized to receive 4 mg endotoxin at 5 h, 24 h, or 72 h before delivery. The endotoxin was solubilized in saline and filtered. The intraamniotic injection was given into the amniotic cavity with ultrasound guidance (8, 11). Preterm lambs were delivered at 125 d gestational age by cesarean section (12). For evaluating lung function 7 d after endotoxin exposure, the preterm lambs were ventilated for 40 min with time-cycled, pressure-limited infant ventilators (11). Peak inspiratory pressures were limited to 40 cm H2O. A pressure transducer (model 8507C-2; Endevco, San Juan Capistrano, CA) and pneumotachograph (model 35-597; Hans Rudolph, Kansas City, MO) were placed between the tracheostomy tube and the ventilator to measure tracheal pressure and flow, respectively. Volume was obtained by integrating flow (12).
|
Measurements on Lungs, Spleen, Plasma, and Cells from Amniotic Fluid and Alveolar Lavage Fluid
Lungs were removed and processed as described (13). The deflation limb of the pressure-volume curve was measured. Saturated phosphatidylcholine (Sat PC) (14, 15), total protein (13, 16), and surfactant proteins (Western blot) were measured (9). The mRNA for the surfactant proteins and for selected cytokines were quantified using sheep-specific probes (9, 10, 17). To reduce the high viscosity, amniotic fluid was incubated at 37° C with N-acetyl-L-cysteine, neuraminidase, and hyaluronidase. Cells from amniotic fluid and alveolar lavage fluid were isolated by centrifugation.
The right upper lobe was inflation fixed at 30 cm H2O. After hematoxylin and eosin staining the tissue was assessed for inflammatory changes (8). Hydrogen peroxide was measured in cells recovered from alveolar lavage fluid of the left lung. Flow cytometry was used to measure
CD11b (
M subunit of integrin CR3) and CD44 (proteoglycan link protein) and the percentage of apoptotic cells was determined by annexin V
and propium iodide staining (20). Enzyme-linked immunosorbent assays
(ELISA) were developed for IL-6 and IL-8 with antibodies from Chemicon (Temecula, CA) and recombinant proteins as standards from
CSIRO (Parkville, Australia). Interferon-gamma (IFN-
) was measured
by ELISA (CSL, Parkville, Australia; recombinant protein was provided
by Dr. S. L. Jones, CSL).
Data Analysis
Results are given as means ± SEM. Inflammatory scores are given as medians with interquartile, 5th and 95th percentile ranges. Comparisons between endotoxin-treated and untreated lambs were by analysis of variance with Student-Newman-Keuls tests used for post-hoc analyses. Tissue scores were compared using the Mann-Whitney nonparametric tests. Significance was accepted at p < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Inflammation and Lung Maturation
There were no differences between the groups in body weights or pH in cord blood (Table 1). Lung function was improved after intraamniotic injection of 4 mg and 10 mg endotoxin given 7 d prior to delivery (Figure 1). Lung gas volumes measured by deflation pressure-volume curves were increased for the 4 and 10 mg dose groups. At 40 cm H2O pressure, volumes were increased from a mean value of 11 ml/kg in control animals to 32-38 ml/kg after endotoxin exposure of 4 mg and 10 mg (Figure 1A). The compliances also were about 2-fold higher after 4 mg or 10 mg endotoxin than in control lambs (Figure 1B). The alveolar surfactant pool size was significantly increased from 0.5 µmol/kg (control) to values over 4 µmol/kg after 4 mg and 10 mg endotoxin (Figure 1C). The mRNAs for surfactant proteins A and C remained elevated 7 d after injection of 4 mg and 10 mg endotoxin (Figure 1D). The dose of 1 mg endotoxin significantly increased SP-C mRNA but not other surfactant proteins.
|
Indicators of Inflammation with Endotoxin Doses
The inflammatory scores in the fetal lung were increased 7 d after the intraamniotic injection of 1, 4, or 10 mg endotoxin in a dose-dependent manner (Figure 2A). The number of inflammatory cells recovered from the alveolar lavage also increased with dose (Figure 2B). The number of granulocytes and monocytes increased significantly after the 0.1 mg and higher doses of endotoxin. Therefore, inflammatory scores and inflammatory cells in alveolar lavages increased for doses of endotoxin that did not induce lung maturation. The increases were dose dependent. After 1, 4, and 10 mg endotoxin there was an increase in inflammatory cells in chorioamniotic membranes (Figure 3A). In all endotoxin-treated animals there were increased numbers of monocytes and lymphocytes in the amniotic fluid (Figure 3B). After doses of 4 mg and 10 mg there was an influx of neutrophils. The absolute number of cells increased in a dose-dependent fashion.
|
|
The white blood cells increased in cord blood 7 d after the 4 mg and 10 mg endotoxin doses (Figure 4A). The neutrophils were the cell type that accounted for most of the increase in cord blood white cells, and the neutrophils were also increased in the animals treated with a dose of 1 mg after 7 d (Figure 4B). The increases in white blood cells and neutrophils were dose dependent. The number of platelets increased in all groups after the 7 day exposure interval, including in the animals that received 0.1 mg endotoxin (Figure 4C).
|
Time Interval for Inflammatory Response
For the animals studied at different time intervals after 4 mg endotoxin the number of total white blood cells in cord blood decreased at 24 h because the lymphocytes decreased and subsequently increased at 7 d due to increased granulocytes (Figure 4D and 4E). The increase in platelets occurred only 7 d after the 4 mg dose of endotoxin (Figure 4F). The increases in cord blood white cells and platelets were late events after endotoxin exposure.
In contrast, inflammatory cytokine mRNAs for IL-1
, IL-6,
IL-8, and tumor necrosis factor-
(TNF-
) increased in the
chorioamnion within 5 h after intraamniotic endotoxin (Figure 5A). The 3- to 7-fold increases were the highest at 5 h. The
increase in expression of TNF-
mRNA was not large at any
time, and the expression of IL-10 mRNA in chorioamnion did
not change at any time. An increase in inflammatory cells in
the amniotic fluid occured by 5 h after the intraamniotic endotoxin and was highest at 72 h (Figure 5C). The cells recovered from the amniotic fluid had a different time pattern of cytokine mRNA expression than did the chorioamnion (Figure
5B). The expression of IL-1
mRNA increased at 24 h and remained elevated at 7 d, IL-8 mRNA was increased at 72 h and 7 d, and IL-6 mRNA did not increase.
|
Inflammatory cells were recruited into the alveolar lavage
by 5 h, and peaked at 72 h (Figure 6A). IL-1
, IL-8, and TNF-
mRNAs were increased in lung tissue only 24 h after endotoxin exposure (Figure 6B). The mRNAs for IL-1
and IL-8
were increased in the alveolar cells recruited to the airways at
24 h and 72 h (Figure 6C). Surfactant protein mRNAs for SP-D
was increased 5 h after 4 mg endotoxin and at all later time
points (Figure 6D). SP-A, B, and C mRNA were increased 24 h
after endotoxin exposure. Activation of cells recruited to the
airways was assessed by measuring the expression of the adhesion molecules (CD11b and CD44) (Figure 7, A and B). The
percentage of positive cells increased at 5 h and was highest at
72 h for both cell surface markers. The numbers of apoptotic
and necrotic cells per body weight in the alveolar lavage also
were the highest at 72 h after endotoxin (Figure 7, C and D).
The cells recruited to the airways at 5 h were highly active based
on the amount of hydrogen peroxide per cell (Figure 7E). However, relative to the number of cells recruited to the airways,
the total amount of hydrogen peroxide normalized to body weight was highest at 24 h (Figure 7F).
|
|
Septemic Inflammation
Several variables were measured to evaluate the systemic inflammation. In cord blood plasma IFN-
was increased 12-fold at 24 h (Figure 8A). IL-6 was increased significantly at 5 h
(Figure 8A). IL-8 was increased from 5 h to 7 d by about 3-fold,
and IL-8 was the only cytokine that was elevated at all time
points measured. The expression of TNF-
mRNA increased
2-fold at 24 h in spleen tissue (Figure 8B). However, the overall cytokine expression pattern indicates minimal cytokine
production by the spleen.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have shown that there was no lung maturation
as indicated by increased lung gas volume, improved compliance, and
increased surfactant Sat PC and increased SP mRNAs
without preceding inflammation in chorioamnion and fetal lung
using various doses of endotoxin. On the other hand, mild inflammation was not followed by lung maturation. The lower
doses of 0.1 mg and 1 mg endotoxin induced an influx of inflammatory cells into the chorioamnion, the amniotic fluid, lung
tissue, and alveolar lavages that persisted 7 d after endotoxin
exposure but lung function was not improved. The increases in
white blood cells and inflammatory cells in fetal lung and alveolar lavage were dose dependent. Even the lowest dose of endotoxin induced an increase in cells in amnoitic fluid and in
platelets indicating a subtle systemic response to the inflammatory stimulus given into the amniotic fluid.
The inflammatory response in the fetal lungs and cord blood increased with endotoxin dose, suggesting that a threshold amount of inflammation was needed to induce the improved lung function. A distinction between local and systemic inflammatory response could not be made after 7 d. We previously found endotoxin doses of 1, 4, 20, or 100 mg caused equivalent maturational exposure without increases in fetal cortisol (11). The variability of response to 1 mg endotoxin may be attributed to the variation in endotoxin preparations. In the fetal sheep model, a dose of 1 or 4 mg given by intraamniotic injection is the minimal stimulus needed to enhance lung function after preterm delivery. There was a clear dose- response relationship between inflammation and the amount of endotoxin. However there were no clearly graded or partial lung maturation responses.
In a previous study we found that 20 mg endotoxin given by
intraamniotic injection increased IL-1
, IL-6, and IL-8 mRNA
in the chorioamnion at 5 h with a parallel response in the lungs beginning at 5 h that increased for about 2 d (10). For this study
we used the minimal effective dose of 4 mg endotoxin for inducing lung maturation and addressed the question whether
systemic versus local inflammation in the fetus was induced
by intraamniotic endotoxin and which compartment was producing proinflammatory cytokines at later time points. The
mRNAs for IL-1
, IL-6, IL-8, and TNF-
were most increased
at 5 h in the chorioamnion. Inflammatory cells in the amniotic
fluid were increased at 5 h, but the 40-fold increase in granulocytes was at 24-72 h, and the up to 35-fold increases in IL-1
and IL-8 mRNA occurred over the 24 h to 7 day interval, with
no increase in IL-6 mRNA. The distinct differences between
chorioamnion and cells in amniotic fluid suggest that the inflammation in amniotic fluid was regulated differently from the response of the chorioamnion. The cytokine response continued in amniotic fluid after it was extinguished in the chorioamnion and fetal lungs.
The mRNAs for the proinflammatory cytokines were increased in lung and alveolar lavage by 24 h, but not at 5 h as noted previously with the higher endotoxin dose (10). The first detectable effect of inflammation in the lungs was the large increase in H2O2 production by the few cells recruited by 5 h. At the same time the mRNA for SP-D was increased. The large number of cells in alveolar lavages at 72 h expressed the surface adhesion molecules CD11b and CD44, which mediate cell recruitment to sites of inflammation. Although the cell surface antigens indicate that many cells evaluated at 72 h were quickly recruited to the airways, they were no longer producing H2O2. We used the measurements of annexin V and counterstaining with propium iodide to evaluate the percentage of apoptotic and necrotic cells in the cell population. Because the total cell numbers increased, we calculated the number of necrotic and apoptotic cells per kilogram body weight, which should best reflect the timing of resolution of inflammation in the lungs. The high numbers of apoptotic and necrotic cells at 72 h indicated resolution of inflammation at 72 h (21). However, complete resolution had not occurred by 7 d, and we found residual inflammatory cells in alveolar lavage as long as 25 d after intraamniotic endotoxin (10).
None of the indicators of inflammation that were detected at 7 days correlated very well with the improved lung function after preterm delivery. Early indicators such as H2O2 and cytokine production in the chorioamnion and the lung cannot be evaluated because those indicators have been extinguished before the physiological maturation response occurs. In mature lungs, endotoxin and proinflammatory cytokines initially suppress the mRNAs for surfactant proteins and the surfactant proteins can rebound to higher levels than normal with healing (17, 22). Although detectable, the mRNAs for SP-A and SP-B are very low at 125 d gestation in the fetal sheep lung, and no decreases are seen after intraamniotic endotoxin. SP-C mRNA should be the most sensitive indicator because it is relatively high at 125 d gestation, and it is unchanged 5 h and increased 24 h after intraamniotic endotoxin. Inflammatory cells producing H2O2 and cytokines were accumulating in the lungs over 3 d, providing a source for direct lung injury. The wet-to-dry weights did not change from control values nor did the total protein in the alveolar lavages (data not shown). However, the antioxidant enzymes catalyse, glutathione peroxidase, and superoxide dismutase are induced after endotoxin exposure, indicating activation of oxidant-mediated pathways in the fetal lung (23). SP-A and SP-D may function as antioxidants (24). SP-D mRNA was increased within 5 h. A hypothesis for the events that result in lung maturation after intraamniotic endotoxin is that neutrophils producing oxidants cause a primary injury and that the fetal lung responds with lung maturation as a protective response.
We previously found that 20 mg intraamniotic endotoxin did
not increase proinflammatory cytokine mRNA in the placenta,
fetal liver, or fetal gut. We used the lower dose of 4 mg endotoxin to search for other indicators of a systemic inflammatory
response. The TNF-
mRNA increased by about 2-fold at 24 h
only in the spleen, with no increase in IL-1
, IL-6, or IL-8, indicating a very minimal response from the fetal spleen. In preterm lambs that were treated with intratracheal endotoxin the
spleen produced high amounts of proinflammatory cytokines
within 6 h demonstrating that the preterm spleen can respond
to a proinflammatory stimulus (25). Nevertheless, IL-6 and
IL-8 were increased in cord plasma over the extended interval
from 24 h to 7 d. Interferon-
also was increased in plasma 12-fold at 24 h. Using IL-8 as a representative proinflammatory
cytokine, we found no increases in mRNA at 72 h or 7 d in
chorioamnion, lung, or spleen. However, the mRNA for IL-8
was elevated in cells in amniotic fluid at 72 h and 7 d, suggesting that the amniotic fluid is the source of the increased cytokine in the cord plasma. As with the other components of the inflammatory response, we cannot specifically link the increased plasma cytokines at 5 h and 24 h to the lung maturation response.
The interpretation of this in vivo model relative to clinical
settings is complex. The preterm human fetus at risk of delivering before 30 wk gestational age may be continuously exposed to live organisms, their products, and inflammatory mediators and the exposure may be prolonged (1). The kinetics
and dynamics of chorioamniotis caused by live organisms are
probably quite different from a single dose of endotoxin from
gram-negative bacteria. The most common microorganism associated with chorioamnionitis is Ureaplasma urealyticum, which
does not have a cell wall but induces IL-1
, IL-6, and TNF-
in amniotic fluid (26). In the clinical literature cord plasma elevations of IL-6 have been used to diagnose systemic inflammation in the fetus (27, 28). We found that there were subtle
indications of systemic inflammation after intraamniotic injection of endotoxin. The increase of IL-6 in cord plasma within 5 h
after intraamniotic endotoxin showed that the systemic inflammation was present at the same time as the local inflammation
in chorioamnion and fetal lung. However, the animals were
not injured in any way that was evident by the endotoxin exposure (8, 9, 11). The antiinflamatory cytokine protein IL-10
was not detectable but sustained increases in IL-8 were in airway samples from infants that developed BPD (29). We found
no significant induction of IL-10 mRNA in membranes, in lung,
or in spleen. IL-8 was increased in plasma at all time points after intraamniotic endotoxin in the fetal sheep. Increased cytokine proteins in cord blood were reported in clinical studies to
be associated with subsequent BPD or cerebral palsy (3, 28)
and interferons can cause cerebral palsy when given to infants
(30). The pattern of cytokine responses in the fetal sheep
elevated IL-8 and IFN-
with no induction of the antiinflammatory cytokine IL-10
parallels the clinical observations that
have been associated with poor lung and neurodevelopmental outcomes (2, 31). In clinical studies oxidative injury has been
implicated in the development of BPD after preterm birth (3).
In our animal model the response of the fetal lung to intraamniotic endotoxin may be different because the oxidant stress is
of short duration.
In summary, we found that intraamniotic doses of 0.1 mg and 1 mg endotoxin induced inflammatory cell recruitment to the chorioamnion and the lungs. However, this inflammation was not accompanied by physiological improvements in lung function. Higher doses of endotoxin sufficient to induce lung maturation were accompanied by systemic inflammation in the fetus within 5 h. Activated cells in the airways producing hydrogen peroxide within 5 h might cause an initial lung injury. Fetal exposure to sufficient inflammation can therefore induce lung maturation, but the precise link between the components and the intensity of the inflamatory response and lung maturation remains elusive.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Alan H. Jobe, M.D., Ph.D., Children's Hospital Medical Center, Division of Pulmonary Biology, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. E-mail: jobea0{at}chmcc.org
(Received in original form March 13, 2001).
This article has an onlline data supplement, which is accessible from this issue's table of contents online at www.atsjournals.orgAcknowledgments: This study was supported by NIH Grant HL-65397, the Women and Infants Research Foundation funding of infrastructural support, and a scholarship from the Deutsche Forschungsgemeinschaft to B. W. K. Commonwealth Scientific and Industrial Research Organisation, Parkville, Australia, provided recombinant ovine interleukin-6 and -8. Dr. S. L. Jones, CSL, Park Ville, Australia, kindly provided recombinant bovine interferon gamma. The probe for SP-D was a kind gift of Dr. M. Hallman, University of Oulu, Finland.
| |
References |
|---|
|
|
|---|
1.
Goldenberg RL,
Hauth JC,
Andrews WW.
Intrauterine infection and
preterm delivery.
N Engl J Med
2000;
342:
1500-1507
2. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-675 [Medline].
3. Speer CP, Groneck P. Oxygen radicals, cytokines, adhesion molecules and lung injury in neonates. Semin Neonatol 1998; 3: 219-228 .
4.
Watterberg KL,
Demers LM,
Scott SM,
Murphy S.
Chorioamnionitis
and early lung inflammation in infants in whom bronchopulmonary
dysplasia develops.
Pediatrics
1996;
97:
210-215
5.
Hannaford K,
Todd DA,
Jefferey H,
John E,
Byth K,
Gilbert GL.
Role
of Ureaplasma urealyticum in lung disease of prematurity.
Arch Dis
Child Fetal Neonatal Ed
1999;
81:
F162-F167
6.
Costeloe K,
Hennessey E,
Gibson AT,
Marlow N,
Wilkinson AR.
The
EPICure study: outcomes to discharge from hospital for infants born
after the threshold of viability.
Pediatrics
2000;
106:
659-671
7. Willet KE, Jobe AH, Ikegami M, Brennan S, Newnham J, Sly PD. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000; 48: 782-788 [Medline].
8. Jobe AH, Newnham JP, Willet KE, Sly P, Ervin MG, Bachurski CJ, Possmayer F, Hallman M, Ikegami M. Antenatal endotoxin and glucocorticoid effects on the lungs of preterm lambs. Am J Obstet Gynecol 2000; 182: 401-408 [Medline].
9.
Bachurski CJ,
Ross GF,
Ikegami M,
Kramer BW,
Jobe AH.
Intra-amniotic endotoxin increases pulmonary surfactant proteins and induces
SP-B processing in fetal sheep.
Am J Physiol
2001;
280:
L279-L285
10.
Kallapur SG,
Willet KE,
Jobe AH,
Ikegami M,
Bachurski CJ.
Intra-amniotic endotoxin: chorioamnionitis precedes lung maturation in preterm lambs.
Am J Physiol
2001;
280:
L527-L536
11.
Jobe AH,
Newnham JP,
Willet KE,
Moss TJ,
Ervin MG,
Padbury JF,
Sly P,
Ikegami M.
Endotoxin-induced lung maturation in preterm lambs
is not mediated by cortisol.
Am J Respir Crit Care Med
2000;
162:
1656-1661
12.
Ikegami M,
Jobe AH,
Newnham J,
Polk DH,
Willet KE,
Sly P.
Repetitive prenatal glucocorticoids improve lung function and decrease growth
in preterm lambs.
Am J Respir Crit Care Med
1997;
156:
178-184
13.
Wada K,
Jobe AH,
Ikegami M.
Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs.
J
Appl Physiol
1997;
83:
1054-1061
14. Mason RJ, Nellenbogen J, Clements JA. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976; 17: 281-284 [Abstract].
15.
Bartlett GR.
Phosphorous assay in column chromatography.
J Biol
Chem
1959;
234:
466-468
16.
Davis AJ,
Jobe AH,
Häfner D,
Ikegami M.
Lung function in premature
lambs and rabbits treated with a recombinant SP-C surfactant.
Am J
Respir Crit Care Med
1998;
157:
553-559
17.
Bachurski CJ,
Pryhuber GS,
Glasser SW,
Kelly SE,
Whitsett JA.
Tumor
necrosis factor-alpha inhibits surfactant protein C gene transcription.
J Biol Chem
1995;
270:
19402-19407
18.
Young AJ,
Hay JB,
Chan JYC.
Primary structure of ovine tumor necrosis alpha cDNA.
Nucleic Acids Res
1990;
18:
6723-6732
19. Martin H, Nash A, Andrews A. Cloning and characterisation of an ovine interleukin-10-encoding cDNA. Gene 1995; 159: 187-191 [Medline].
20. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescin labeled Annexin V. J Immunol Methods 1995; 184: 39-51 [Medline].
21. Mann CL, Cidloski JA. Signaling cascades of apoptosis. In: Winkler JD, editor. Apoptosis and inflammation. Basel: Birkhäuser, 1999; p. 7-18.
22.
Pryhuber GS,
Bachurski C,
Hirsch R,
Bacon A,
Whitsett JA.
Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine
lung.
Am J Physiol
1996;
270:
L714-L721
23. Sosenko IRS, Jobe AH. Intraamniotic endotoxin: promotion of lung antioxidant enzyme activity in preterm lambs precedes maturation of lung function and surfactant [abstract]. Pediatr Res 2001; 49: 383A .
24.
Bridges JP,
Davis HW,
Damodarasamy M,
Kuroki Y,
Howles G,
Hui DY,
McCormack FX.
Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative injury.
J Biol
Chem
2000;
275:
38848-38855
25. Kramer BW, Jobe AH, Ikegami M. Systemic inflammation following intratracheal endotoxin that leaks into the circulation despite gentle ventilation of preterm lambs [abstract]. Am J Respir Crit Care Med 2001; 163: A209 .
26. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, Kim KS. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998; 179: 1254-1260 [Medline].
27. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 179: 1254-1260 .
28. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202 [Medline].
29. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible development basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-975 [Medline].
30. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, MacDonald D, Folkman J, Ezekowitz RA. Spastic diplegia as a complication of interferon alpha-2a treatment of hemangiomas in infancy. J Pediatr 1998; 132: 527-530 [Medline].
31. Grether JK, Nelson KB, Dambrosia JM, Phillips TM. Interferons and cerebral palsy. J Pediatr 1999; 134: 324-332 [Medline].
This article has been cited by other articles:
![]() |
D. D. Jenkins, E. Chang, and I. Singh Neuroprotective Interventions: Is It Too Late? J Child Neurol, September 1, 2009; 24(9): 1212 - 1219. [Abstract] [PDF] |
||||
![]() |
B. W. Kramer, S. G. Kallapur, T. J. Moss, I. Nitsos, J. P. Newnham, and A. H. Jobe Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep Innate Immunity, April 1, 2009; 15(2): 101 - 107. [Abstract] [PDF] |
||||
![]() |
F.-C. Cheah, J. J. Pillow, B. W. Kramer, G. R. Polglase, I. Nitsos, J. P. Newnham, A. H. Jobe, and S. G. Kallapur Airway inflammatory cell responses to intra-amniotic lipopolysaccharide in a sheep model of chorioamnionitis Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L384 - L393. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, A. H. Jobe, M. K. Ball, I. Nitsos, T. J. M. Moss, N. H. Hillman, J. P. Newnham, and B. W. Kramer Pulmonary and Systemic Endotoxin Tolerance in Preterm Fetal Sheep Exposed to Chorioamnionitis J. Immunol., December 15, 2007; 179(12): 8491 - 8499. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Hillman, T. J. M. Moss, S. G. Kallapur, C. Bachurski, J. J. Pillow, G. R. Polglase, I. Nitsos, B. W. Kramer, and A. H. Jobe Brief, Large Tidal Volume Ventilation Initiates Lung Injury and a Systemic Response in Fetal Sheep Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Kramer, S. N. Joshi, T. J. M. Moss, J. P. Newnham, R. Sindelar, A. H. Jobe, and S. G. Kallapur Endotoxin-induced maturation of monocytes in preterm fetal sheep lung Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L345 - L353. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kunzmann, C. P. Speer, A. H. Jobe, and B. W. Kramer Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L223 - L231. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nitsos, S. M. Rees, J. Duncan, B. W. Kramer, R. Harding, J. P. Newnham, and T. J. M. Moss Chronic Exposure to Intra-Amniotic Lipopolysaccharide Affects the Ovine Fetal Brain Reproductive Sciences, May 1, 2006; 13(4): 239 - 247. [Abstract] [PDF] |
||||
![]() |
S G Kallapur and A H Jobe Contribution of inflammation to lung injury and development. Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2006; 91(2): F132 - F135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, T. J. M. Moss, M. Ikegami, R. L. Jasman, J. P. Newnham, and A. H. Jobe Recruited Inflammatory Cells Mediate Endotoxin-induced Lung Maturation in Preterm Fetal Lambs Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1315 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, I. Nitsos, T. J. M. Moss, B. W. Kramer, J. P. Newnham, M. Ikegami, and A. H. Jobe Chronic endotoxin exposure does not cause sustained structural abnormalities in the fetal sheep lungs Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L966 - L974. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Kramer, M. Ikegami, T. J. M. Moss, I. Nitsos, J. P. Newnham, and A. H. Jobe Endotoxin-induced Chorioamnionitis Modulates Innate Immunity of Monocytes in Preterm Sheep Am. J. Respir. Crit. Care Med., January 1, 2005; 171(1): 73 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, C. J. Bachurski, T. D. L. Cras, S. N. Joshi, M. Ikegami, and A. H. Jobe Vascular changes after intra-amniotic endotoxin in preterm lamb lungs Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1178 - L1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Land and F. Darakhshan Thymulin evokes IL-6-C/EBP{beta} regenerative repair and TNF-{alpha} silencing during endotoxin exposure in fetal lung explants Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L473 - L487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikegami, S. G. Kallapur, and A. H. Jobe Initial responses to ventilation of premature lambs exposed to intra-amniotic endotoxin 4 days before delivery Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L573 - L579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rounioja, J. Rasanen, V. Glumoff, M. Ojaniemi, K. Makikallio, and M. Hallman Intra-amniotic lipopolysaccharide leads to fetal cardiac dysfunction: A mouse model for fetal inflammatory response Cardiovasc Res, October 15, 2003; 60(1): 156 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikegami, T. J. M. Moss, S. G. Kallapur, N. Mulrooney, B. W. Kramer, I. Nitsos, C. J. Bachurski, J. P. Newnham, and A. H. Jobe Minimal lung and systemic responses to TNF-{alpha} in preterm sheep Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L121 - L129. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, B. W. Kramer, T. J. M. Moss, J. P. Newnham, A. H. Jobe, M. Ikegami, and C. J. Bachurski Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L633 - L642. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kallapur, A. H. Jobe, M. Ikegami, and C. J. Bachurski Increased IP-10 and MIG Expression after Intra-amniotic Endotoxin in Preterm Lamb Lung Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 779 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Kramer, S. Kramer, M. Ikegami, and A. H. Jobe Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L452 - L459. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. M. Moss, M. G. Davey, R. Harding, and J. P. Newnham Effects of Intra-Amniotic Endotoxin on Lung Structure and Function Two Months After Term Birth in Sheep Reproductive Sciences, July 1, 2002; 9(4): 220 - 225. [Abstract] [PDF] |
||||
![]() |
D. Warburton Sound the Tocsin! Beware Adverse Effects of Lung Inflammation Early in Gestation Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 741 - 742. [Full Text] [PDF] |
||||
![]() |
I. Nitsos, T. J. M. Moss, M. L. Cock, R. Harding, and J. P. Newnham Fetal Responses to Intra-Amniotic Endotoxin in Sheep Reproductive Sciences, March 1, 2002; 9(2): 80 - 85. [Abstract] [PDF] |
||||
![]() |
M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF] |
||||
![]() |
B. W. KRAMER, M. IKEGAMI, and A. H. JOBE Intratracheal Endotoxin Causes Systemic Inflammation in Ventilated Preterm Lambs Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 463 - 469. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |